Melatonin Mylan

Melatonin, the active ingredient in Melatonin Mylan, is a melatonin receptor agonist presented as an oral dosage form for oral use. By binding to MT1 and MT2 receptors in the suprachiasmatic nucleus, it helps regulate the circadian rhythm and is used to manage insomnia and jet‑lag in adults.

GNH USA supplies Melatonin Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers.

Melatonin acts on melatonin receptors to support the regulation of the sleep‑wake cycle.

Insomnia: reduces sleep onset latency and improves total sleep time in adults. Jet lag: helps realign circadian rhythm after rapid east‑west travel, reducing daytime sleepiness. Circadian rhythm disturbances: supports adjustment of sleep patterns in shift‑work or delayed sleep phase syndrome.

Melatonin is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Drowsiness or daytime sleepiness - Headache - Dizziness - Nausea or mild gastrointestinal discomfort

Serious or Rare Side Effects: - Allergic reactions such as rash, itching, or angioedema - Severe dizziness or fainting - Mood changes including depression or agitation (rare)

When considering melatonin therapy, several precautions should be observed.

- Pregnancy: consult a healthcare professional before use. - Breastfeeding: discuss potential risks with a physician. - Concomitant CNS depressants: monitor for additive sedation. - Underlying medical conditions: use caution in epilepsy, depression, or autoimmune disorders. - Driving or operating machinery: avoid until individual response is known. - Store at ambient temperature: keep in original container, protect from moisture and light.

Melatonin may interact with other medicines; awareness of key interactions helps ensure safety.

Major Interactions (Avoid): - CYP1A2 inhibitors (e.g., fluvoxamine): may increase melatonin plasma levels. - Sedative CNS depressants (e.g., benzodiazepines, barbiturates): risk of excessive sedation.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): possible alteration of bleeding risk. - Antidiabetic agents: melatonin may affect glucose control. - Oral contraceptives: may raise melatonin concentrations.